-The Economic Times There has been a change of guard at the power ministry and Jyotiraditya Scindia, the new man in charge, has described his task as daunting. To simplify the many complexities, it's worth keeping in mind an adage that's particularly apt for rural India: Nothing is more expensive than no power. While on one hand there are thousands of villages that still remain to be electrified, on the other even...

-The New York Times Blog The strength and direction of the Indian economy may be up for debate, but one remarkable fact is not: There has been massive growth in the number and wealth of billionaires in India since the economic liberalization measures in 1991. The phenomenon has often been compared to the United States’ experience in the latter part of the 19th century. This was a period evocatively described by Mark...

-Tehelka The sentencing of Wall Street wizard Rajat Gupta in the historic insider trading case has led to the fall of a one-time icon for many Indians “This is where destiny is taking me.” This is what former Goldman Sachs Group Inc director, Rajat Gupta, told old friend Pramod Bhasin, as he sat with a glass of scotch in hand, in a mid-town bar in New York. Little did Gupta know how prophetic...

-The Hindu The Delhi High Court order dismissing a challenge to the Bus Rapid Transit System in the national capital is praiseworthy for its assertion that the urban commons, represented by road space, is a public good. The judgment correctly observes that governments pursue the principal purpose of promoting welfare of the maximum number of people, rather than distributing public goods in a restrictive manner. Delightfully, the court makes short work...

-Live Mint There are also ways in which we can help Indian institutions that have come to us seeking access to our technologies Bangalore: A key perception change is emerging in the global pharmaceutical industry on the long-established divide between the so-called generics and innovative business. While the two are still at loggerheads in several developed as well as developing markets, the world’s top drugmakers are reinventing the wheel. Paris-based Sanofi SA,...